Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 9 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Vaxcyte, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 295 | 6 | 336 | +47 |
| Shares | 147.6M | 13.4M | 162.5M | +28.4M (+21.2%) |
| Value | $6.81B | $620.1M | $9.44B | +$3.25B (+52.5%) |
6 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (71)
Institutions that held Vaxcyte, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (24)
Institutions that held Vaxcyte, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| EcoR1 Capital, LLC | 450,000 | $20.8M |
| Citadel Advisors LLC | 326,574 | $15.1M |
| Tang Capital Management LLC | 275,000 | $12.7M |
| Jump Financial, LLC | 89,822 | $4.14M |
| Harbor Capital Advisors, Inc. | 31,274 | $1.44M |
| Alberta Investment Management Corp | 30,100 | $1.39M |
| Aquatic Capital Management LLC | 24,485 | $1.13M |
| Verition Fund Management LLC | 15,731 | $725.8K |
| Quest Partners LLC | 10,513 | $485.1K |
| Perbak Capital Partners LLP | 8,899 | $410.6K |
| Mackenzie Financial Corp | 7,174 | $325.1K |
| Qsemble Capital Management, LP | 6,701 | $309.2K |
| Quantbot Technologies LP | 5,399 | $249.1K |
| Two Sigma Securities, LLC | 5,025 | $231.9K |
| Neo Ivy Capital Management | 4,803 | $221.6K |
| Clearstead Advisors, LLC | 3,635 | $167.7K |
| Simplex Trading, LLC | 1,549 | $71.5K |
| Group One Trading, L.P. | 831 | $38.3K |
| International Assets Investment Management, LLC | 200 | $9.23K |
| SageView Advisory Group, LLC | 114 | $5.26K |
| Turning Point Benefit Group, Inc. | 20 | $922 |
| Financial Network Wealth Advisors LLC | 15 | $692 |
| Root Financial Partners, LLC | 3 | $138 |
| Private Wealth Asset Management, LLC | 2 | $92 |
Not filed for Q1 2026 yet (6)
Institutions that held Vaxcyte, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 12,193,986 | $562.6M |
| Norges Bank | 1,228,939 | $56.7M |
| CIBC Private Wealth Group, LLC | 7,756 | $357.9K |
| CIBC World Markets Corp | 7,575 | $349.5K |
| Comerica Bank | 1,103 | $50.9K |
| Global Retirement Partners, LLC | 181 | $8.35K |